Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q2 FY26 results · Jul–Sep 2025
Krishna Institute of Medical Sciences reported revenue from operations of ₹960.70 crore (up 23.6% from Q2 FY25) and net profit of ₹72.00 crore (down 40.3% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 960.70 | 777.30 | +23.6% | 871.60 | +10.2% |
| Other income | 4.20 | 5.00 | −16.0% | 7.10 | −40.8% |
| Total income | 964.90 | 782.30 | +23.3% | 878.70 | +9.8% |
| Profit before tax | 96.80 | 162.20 | −40.3% | 113.70 | −14.9% |
| Net profit for the period | 72.00 | 120.70 | −40.3% | 85.00 | −15.3% |
| Attributable to shareholders of the company | 67.10 | 107.40 | −37.5% | 78.60 | −14.6% |
| EPS, basic (₹) | 1.67 | 2.68 | −37.7% | 1.96 | −14.8% |
| Net margin (%) | 7.5 | 15.5 | 9.8 |
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 430.00 | 363.30 | +18.4% | 373.40 | +15.2% |
| Other income | 12.50 | 6.60 | +89.4% | 12.20 | +2.5% |
| Total income | 442.50 | 369.90 | +19.6% | 385.60 | +14.8% |
| Profit before tax | 86.10 | 99.10 | −13.1% | 79.70 | +8.0% |
| Net profit for the period | 63.50 | 72.20 | −12.0% | 58.80 | +8.0% |
| EPS, basic (₹) | 1.59 | 1.80 | −11.7% | 1.47 | +8.2% |
| Net margin (%) | 14.8 | 19.9 | 15.7 |
Consolidated
- Filed with BSE
- 07 Nov 2025, 16:25 IST
- Board meeting
- 07 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Nov 2025, 16:25 IST
- Board meeting
- 07 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE